nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Gastrointestinal ulcer haemorrhage—Methotrexate—systemic scleroderma	0.045	0.045	CcSEcCtD
Telavancin—Necrosis—Captopril—systemic scleroderma	0.0313	0.0313	CcSEcCtD
Telavancin—Fluid overload—Mycophenolic acid—systemic scleroderma	0.0311	0.0311	CcSEcCtD
Telavancin—Ulcer—Mometasone—systemic scleroderma	0.0296	0.0296	CcSEcCtD
Telavancin—Fluid overload—Lisinopril—systemic scleroderma	0.028	0.028	CcSEcCtD
Telavancin—Ulcer—Captopril—systemic scleroderma	0.026	0.026	CcSEcCtD
Telavancin—Abscess—Leflunomide—systemic scleroderma	0.0256	0.0256	CcSEcCtD
Telavancin—Fluid overload—Mycophenolate mofetil—systemic scleroderma	0.0245	0.0245	CcSEcCtD
Telavancin—Abscess—Mycophenolic acid—systemic scleroderma	0.0244	0.0244	CcSEcCtD
Telavancin—Hyperkalaemia—Captopril—systemic scleroderma	0.0241	0.0241	CcSEcCtD
Telavancin—Ulcer—Leflunomide—systemic scleroderma	0.0214	0.0214	CcSEcCtD
Telavancin—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0195	0.0195	CcSEcCtD
Telavancin—Abscess—Mycophenolate mofetil—systemic scleroderma	0.0193	0.0193	CcSEcCtD
Telavancin—Hyperkalaemia—Mycophenolic acid—systemic scleroderma	0.019	0.019	CcSEcCtD
Telavancin—Hyponatraemia—Captopril—systemic scleroderma	0.0179	0.0179	CcSEcCtD
Telavancin—Hyperkalaemia—Lisinopril—systemic scleroderma	0.0171	0.0171	CcSEcCtD
Telavancin—Phlebitis—Mycophenolic acid—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Telavancin—Hyperkalaemia—Mycophenolate mofetil—systemic scleroderma	0.015	0.015	CcSEcCtD
Telavancin—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.014	0.014	CcSEcCtD
Telavancin—Flatulence—Pentoxifylline—systemic scleroderma	0.014	0.014	CcSEcCtD
Telavancin—Necrosis—Prednisone—systemic scleroderma	0.0132	0.0132	CcSEcCtD
Telavancin—Abscess—Prednisone—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Telavancin—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Telavancin—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Telavancin—Hyponatraemia—Lisinopril—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Telavancin—Infection—Pentoxifylline—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Telavancin—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Telavancin—Necrosis—Methotrexate—systemic scleroderma	0.011	0.011	CcSEcCtD
Telavancin—Ulcer—Prednisone—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Telavancin—Abscess—Methotrexate—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Telavancin—Infection—Mometasone—systemic scleroderma	0.00991	0.00991	CcSEcCtD
Telavancin—Extravasation—Methotrexate—systemic scleroderma	0.00989	0.00989	CcSEcCtD
Telavancin—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00914	0.00914	CcSEcCtD
Telavancin—Ulcer—Methotrexate—systemic scleroderma	0.00913	0.00913	CcSEcCtD
Telavancin—Flatulence—Leflunomide—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Telavancin—Flatulence—Mycophenolic acid—systemic scleroderma	0.00832	0.00832	CcSEcCtD
Telavancin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Telavancin—Body temperature increased—Mometasone—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Telavancin—Infection—Azathioprine—systemic scleroderma	0.0076	0.0076	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.0075	0.0075	CcSEcCtD
Telavancin—Flatulence—Lisinopril—systemic scleroderma	0.00749	0.00749	CcSEcCtD
Telavancin—Vomiting—Pentoxifylline—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Telavancin—Rash—Pentoxifylline—systemic scleroderma	0.00729	0.00729	CcSEcCtD
Telavancin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00728	0.00728	CcSEcCtD
Telavancin—Infection—Leflunomide—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Telavancin—Body temperature increased—Captopril—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Telavancin—Nausea—Pentoxifylline—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Telavancin—Infection—Mycophenolic acid—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Telavancin—Diarrhoea—Mometasone—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Telavancin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Telavancin—Vomiting—Mometasone—systemic scleroderma	0.00634	0.00634	CcSEcCtD
Telavancin—Rash—Mometasone—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Telavancin—Dermatitis—Mometasone—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Telavancin—Infection—Lisinopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Telavancin—Body temperature increased—Azathioprine—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Telavancin—Diarrhoea—Captopril—systemic scleroderma	0.006	0.006	CcSEcCtD
Telavancin—Nausea—Mometasone—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Telavancin—Body temperature increased—Leflunomide—systemic scleroderma	0.00571	0.00571	CcSEcCtD
Telavancin—Vomiting—Captopril—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Telavancin—Rash—Captopril—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Telavancin—Dermatitis—Captopril—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Telavancin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Telavancin—Infection—Mycophenolate mofetil—systemic scleroderma	0.0054	0.0054	CcSEcCtD
Telavancin—Diarrhoea—Azathioprine—systemic scleroderma	0.00523	0.00523	CcSEcCtD
Telavancin—Nausea—Captopril—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Telavancin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Telavancin—Diarrhoea—Leflunomide—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Telavancin—Body temperature increased—Lisinopril—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Telavancin—Vomiting—Azathioprine—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Telavancin—Rash—Azathioprine—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Telavancin—Dermatitis—Azathioprine—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Telavancin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Telavancin—Vomiting—Leflunomide—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Telavancin—Rash—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Telavancin—Dermatitis—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Telavancin—Nausea—Azathioprine—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Telavancin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Telavancin—Rash—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Telavancin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Telavancin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Telavancin—Nausea—Leflunomide—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Telavancin—Diarrhoea—Lisinopril—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Telavancin—Nausea—Mycophenolic acid—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Telavancin—Vomiting—Lisinopril—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Telavancin—Rash—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Telavancin—Dermatitis—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Telavancin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Telavancin—Nausea—Lisinopril—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Telavancin—Infection—Prednisone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Telavancin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Telavancin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Telavancin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Telavancin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Telavancin—Infection—Methotrexate—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Telavancin—Body temperature increased—Prednisone—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Telavancin—Diarrhoea—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Telavancin—Body temperature increased—Methotrexate—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Telavancin—Vomiting—Prednisone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Telavancin—Rash—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Telavancin—Dermatitis—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Telavancin—Nausea—Prednisone—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Telavancin—Diarrhoea—Methotrexate—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Telavancin—Vomiting—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Telavancin—Rash—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Telavancin—Dermatitis—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Telavancin—Nausea—Methotrexate—systemic scleroderma	0.00183	0.00183	CcSEcCtD
